This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perloff, J. K. Articles by Miner, P. D. Search for Related Content PubMed PubMed Citation Articles by Perloff, J. K. Articles by Miner, P. D.

Circulation, Vol 87, 1954-1959, Copyright © 1993 by American Heart Association

ARTICLES

Risk of stroke in adults with cyanotic congenital heart disease

JK Perloff, AJ Marelli and PD Miner
Department of Medicine, University of California Los Angeles.

BACKGROUND. Adults with cyanotic congenital heart disease and elevated hematocrit levels are often phlebotomized because of an assumed risk of cerebral arterial thrombotic stroke. Whether a relation exists between hematocrit level, symptomatic erythrocytosis (hyperviscosity), and stroke remains to be established in this patient population. METHODS AND RESULTS. Accordingly, 112 cyanotic patients 19-74 years old (mean, 36 +/- 11.7 years) in the UCLA Adult Congenital Heart Disease Center Registry were selected for study by virtue of continuous observation for 1-12 years (total, 748 patient-years). Patients with independent risk factors for embolic or vasospastic stroke were excluded. The study patients were then divided into two groups: 1) compensated erythrocytosis (stable hematocrit levels of 46.0-72.7% [mean, 57.5 +/- 7.2%], iron replete, absent or mild hyperviscosity symptoms), and 2) decompensated erythrocytosis (unstable rising hematocrit levels of 61.5- 75.0% [mean, 69.5 +/- 10.6%], iron deficiency, marked-to-severe hyperviscosity symptoms). No patient with either compensated or decompensated erythrocytosis, irrespective of hematocrit level, iron stores, or the presence, degree, or recurrence of cerebral hyperviscosity symptoms, progressed to clinical evidence of a complete stroke (cerebral arterial thrombosis with brain infarction). CONCLUSIONS. Because a risk of stroke caused by cerebral arterial thrombosis was not demonstrated, because the circulatory effects of phlebotomy are transient, and because of the untoward sequelae of phlebotomy-induced iron deficiency, we recommend phlebotomy for the temporary relief of significant, intrusive hyperviscosity symptoms but not for the hematocrit level per se. According to our data, phlebotomy is not warranted to reduce an assumed risk of stroke because that risk did not materialize.

This article has been cited by other articles:

				H. Laks, D. Marelli, M. Plunkett, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464. [Full Text]

				G.-P. Diller and M. A. Gatzoulis Pulmonary Vascular Disease in Adults With Congenital Heart Disease Circulation, February 27, 2007; 115(8): 1039 - 1050. [Abstract] [Full Text] [PDF]

				P. Khairy, N. Poirier, and L.-A. Mercier Univentricular Heart Circulation, February 13, 2007; 115(6): 800 - 812. [Abstract] [Full Text] [PDF]

				C. S. Broberg, B. E. Bax, D. O. Okonko, M. W. Rampling, S. Bayne, C. Harries, S. J. Davidson, A. Uebing, A. A. Khan, S. Thein, et al. Blood Viscosity and its Relationship to Iron Deficiency, Symptoms, and Exercise Capacity in Adults With Cyanotic Congenital Heart Disease J. Am. Coll. Cardiol., July 18, 2006; 48(2): 356 - 365. [Abstract] [Full Text] [PDF]

				G.-P. Diller, K. Dimopoulos, C. S. Broberg, M. G. Kaya, U. S. Naghotra, A. Uebing, C. Harries, O. Goktekin, J. S. R. Gibbs, and M. A. Gatzoulis Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study Eur. Heart J., July 2, 2006; 27(14): 1737 - 1742. [Abstract] [Full Text] [PDF]

				P. Khairy, M. J. Landzberg, M. A. Gatzoulis, L.-A. Mercier, S. M. Fernandes, J.-M. Cote, J.-P. Lavoie, A. Fournier, P. G. Guerra, A. Frogoudaki, et al. Transvenous Pacing Leads and Systemic Thromboemboli in Patients With Intracardiac Shunts: A Multicenter Study Circulation, May 23, 2006; 113(20): 2391 - 2397. [Abstract] [Full Text] [PDF]

				H Horigome, N Iwasaki, I Anno, S Kurachi, and K Kurachi Magnetic resonance imaging of the brain and haematological profile in adult cyanotic congenital heart disease without stroke Heart, February 1, 2006; 92(2): 263 - 265. [Full Text] [PDF]

				P. Engelfriet, E. Boersma, E. Oechslin, J. Tijssen, M. A. Gatzoulis, U. Thilen, H. Kaemmerer, P. Moons, F. Meijboom, J. Popelova, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period: The Euro Heart Survey on adult congenital heart disease Eur. Heart J., November 1, 2005; 26(21): 2325 - 2333. [Abstract] [Full Text] [PDF]

				J. Shibata, J. Hasegawa, H.-J. Siemens, E. Wolber, L. Dibbelt, D. Li, D. M. Katschinski, J. Fandrey, W. Jelkmann, M. Gassmann, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis Blood, June 1, 2003; 101(11): 4416 - 4422. [Abstract] [Full Text] [PDF]

				H. Laks, D. Marelli, M. Plunkett, J. Odim, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1329 - 1358. [Full Text]

				K. Niwa, J. K. Perloff, S. Kaplan, J. S. Child, and P. D. Miner Eisenmenger syndrome in adults: Ventricular septal defect, truncus arteriosus, univentricular heart J. Am. Coll. Cardiol., July 1, 1999; 34(1): 223 - 232. [Abstract] [Full Text] [PDF]

				S A THORNE Management of polycythaemia in adults with cyanotic congenital heart disease Heart, April 1, 1998; 79(4): 315 - 316. [Full Text]